Darmiyan secures FDA approval for BrainSee prognostic test
Braintree, the first clinical application of Darmiyan’s patented core technology, is a fully automated platform that combines standard…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Jan 24
Braintree, the first clinical application of Darmiyan’s patented core technology, is a fully automated platform that combines standard…
12 Jan 24
Axon Therapy leverages magnetic peripheral nerve stimulation (mPNS) in sessions lasting 13.5 minutes each, to provide a non-pharmacological…
12 Jan 24
The latest generation of Zeiss femtosecond lasers offer rapid treatment, more flexibility, and major workflow upgrades for surgically…
12 Jan 24
The acquisition of Superior Tooling will help SHL strengthen its in-house manufacturing capabilities and support its upcoming US…
12 Jan 24
SlideMate Laser, the latest addition to Epredia’s SlideMate portfolio of slide printers, is designed for clinical laboratories of…
12 Jan 24
Designed for drug-free treatment of mental health conditions from the privacy of one’s home with virtual monitoring by…
11 Jan 24
As part of the partnership, Ultromics will research and secure the US Food and Drug Administration (FDA) approval…
11 Jan 24
The Cavux FFS-LX is an integrated cage and screw system designed to be implanted bilaterally in the facet…
11 Jan 24
Innersight Labs has developed a software-only product, Innersight3D, that enables surgeons to generate a patient-specific 3D model from…
11 Jan 24
The approval underscores Pulsenmore's commitment to transforming the landscape of prenatal care, offering a groundbreaking solution for expectant…